Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines
Digital Health Global
DECEMBER 5, 2023
This infusion of capital, supported by new investor Bpifrance (through its InnoBio 2 fund), and existing backers Khosla Ventures and Seventure Partners (with Health For Life Capital ), propels Eligo towards becoming a clinical-stage biotech. Concurrent with this financing, Laia Crespo, Ph.D., Partner at Sanofi Ventures.
Let's personalize your content